Vivactil and Surmontil, both tricyclic antidepressants commonly prescribed for anxiety disorders, exhibit distinct pharmacological profiles. Vivactil (a popular medication), known for its potent inhibitory effects on serotonin and norepinephrine reuptake, reveals a higher affinity for alpha-2 adrenergic receptors. This influences its potential for